Strong earnings release with revenue growing at 100% yoy, earnings still negative. Has overshot the 50% fib level. Previous support at around $6 per share, dip buying around that area could be a reasonable trade.
Usually clinical data isn't super positive on day 2 but these guys recently raised money, Point72 bought into the company. Almost no shares to short out there.
Today I expect this to trade around 2.15 in decent size. Looking to buy on dips for instant profit and potentially hold some for a run up to $3
Positive P2 clinical trial data came out on a similar product that failed P3 trials earlier in the year rendering the company almost worthless. Spiked to its cash balance after market. There's potential for this to spike higher a bit like ONCS if ppl think the company has hope.
Buy pre-market for a morning spike in the 7-8 range
Dip buy a...
At current run rate company is pulling in 500m in revenue growing at 50%. Prob trades at 5x P/S, a price of $25 per share today given that this is hugely hyped up. So much hype already though, best risk reward is on a dip buy.
Earnings winner, wouldn't be surprised if this grinds higher during trading sessions. Entire float traded on Friday though so have to expect volume to start tapering off and with that possible afternoon fades and gap downs on thinner liquidity.
Seeing a second dead cat bounce here as a volume surge came in midday Friday. This midday action can be profitably faded >50% of the time. Previous dead cat bounce on 2x ADV failed. Suspect this will too. Could see an initial spike on the open would look to short more at the 2.40 mark for a fade down to 1.80ish
After the insane spike every day trader out there is probably going to put this on watch and attempt to day trade this, and let's be honest, 90% will fail. $7 looks like potential support on a 2-day time period. Lets go for dip-buy there, potential hold overnight into gap up Tuesday.
Previous FDA winner on new surgical device. Puked after popping now stable. Could see run into earnings here up to 3.70 per share. Note that $50m financing deal is ongoing but this shouldn't have huge impact in the short term.
Interestingly had another final hour leg up on 03-Nov which was the pattern observed before the gap and breakout on 02-Nov. Original news has most likely run its course, 14m+ shares been trading with a 5m float. Trying to short here on gap-up for a crack.
XNET, a huge runner over the past two weeks. #GAP-UP has been a consistently performing trade, however in the last two days #GAP-DOWN has come into the money despite the presence of brutal morning spikes. If shorts get deterred from playing gap-down here, we could see huge potential gap-down profits, ideally a slow and steady decline to hit gap-down profits day...